recommended

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ in Elderly and Updates to the Prescribing Information

Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

1 week ago

CeraVe Celebrates Two Decades of “Developed with Dermatologists” Skincare: A 20th Birthday Tribute to Skin Barrier Science and Innovations

A Global Celebration Unites Dermatologists, Influencers, and Innovators in New York City to Mark 20 Years of the Iconic Skincare…

3 weeks ago